Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia

Yasuo Hirayama; Takeshi Terui; Kazuhiko Koike; Hiroshi Neda; Kunihiko Ishitani; Kyuhei Kohda; Hiroyuki Kuroda; Satoshi Iyama; Tsutomu Sato; Masayoshi Kobune; Rishu Takimoto; Junji Kato

Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia

Yasuo Hirayama^*, Takeshi Terui, Kazuhiko Koike, Hiroshi Neda, Kunihiko Ishitani, Kyuhei Kohda, Hiroyuki Kuroda, Satoshi Iyama, Tsutomu Sato, Masayoshi Kobune, Rishu Takimoto, Junji Kato

^*この論文の責任著者

血液内科

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

抄録

The institutional review board of our hospital approved FLAG-MG therapy (G-CSF 300 microg day 1-6, fludarabin 30 mg/m(2) day 2-6, Ara-C 1 g/m(2) day 2-6, mitoxantrone 5 mg/m(2) day 2-4, gemtuzumab ozogamicin 3 mg/m(2) day 9) for relapsed or refractory elderly acute myeloid leukemia patients. We conducted this therapy for two refractory patients aged 56 and 63 and one relapsed 58-year-old patient. All three patients were induced complete remission after FLAG-MG therapy without serious complications.

本文言語	英語
ページ（範囲）	663-665
ページ数	3
ジャーナル	[Rinshō ketsueki] The Japanese journal of clinical hematology
巻	50
号	8
出版ステータス	出版済み - 2009/08

ASJC Scopus 主題領域

医学一般

フィンガープリント

「Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Hirayama, Y., Terui, T., Koike, K., Neda, H., Ishitani, K., Kohda, K., Kuroda, H., Iyama, S., Sato, T., Kobune, M., Takimoto, R., & Kato, J. (2009). Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia. [Rinshō ketsueki] The Japanese journal of clinical hematology, 50(8), 663-665.

@article{e376e1ed36fe4446b690f88a870974b7,

title = "Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia",

abstract = "The institutional review board of our hospital approved FLAG-MG therapy (G-CSF 300 microg day 1-6, fludarabin 30 mg/m(2) day 2-6, Ara-C 1 g/m(2) day 2-6, mitoxantrone 5 mg/m(2) day 2-4, gemtuzumab ozogamicin 3 mg/m(2) day 9) for relapsed or refractory elderly acute myeloid leukemia patients. We conducted this therapy for two refractory patients aged 56 and 63 and one relapsed 58-year-old patient. All three patients were induced complete remission after FLAG-MG therapy without serious complications.",

author = "Yasuo Hirayama and Takeshi Terui and Kazuhiko Koike and Hiroshi Neda and Kunihiko Ishitani and Kyuhei Kohda and Hiroyuki Kuroda and Satoshi Iyama and Tsutomu Sato and Masayoshi Kobune and Rishu Takimoto and Junji Kato",

year = "2009",

month = aug,

language = "英語",

volume = "50",

pages = "663--665",

journal = "[Rinshō ketsueki] The Japanese journal of clinical hematology",

issn = "0485-1439",

publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",

number = "8",

}

Hirayama, Y, Terui, T, Koike, K, Neda, H, Ishitani, K, Kohda, K, Kuroda, H, Iyama, S, Sato, T, Kobune, M, Takimoto, R & Kato, J 2009, 'Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia', [Rinshō ketsueki] The Japanese journal of clinical hematology, vol. 50, no. 8, pp. 663-665.

Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia. / Hirayama, Yasuo; Terui, Takeshi; Koike, Kazuhiko その他.
In: [Rinshō ketsueki] The Japanese journal of clinical hematology, Vol. 50, No. 8, 08.2009, p. 663-665.

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

TY - JOUR

T1 - Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia

AU - Hirayama, Yasuo

AU - Terui, Takeshi

AU - Koike, Kazuhiko

AU - Neda, Hiroshi

AU - Ishitani, Kunihiko

AU - Kohda, Kyuhei

AU - Kuroda, Hiroyuki

AU - Iyama, Satoshi

AU - Sato, Tsutomu

AU - Kobune, Masayoshi

AU - Takimoto, Rishu

AU - Kato, Junji

PY - 2009/8

Y1 - 2009/8

N2 - The institutional review board of our hospital approved FLAG-MG therapy (G-CSF 300 microg day 1-6, fludarabin 30 mg/m(2) day 2-6, Ara-C 1 g/m(2) day 2-6, mitoxantrone 5 mg/m(2) day 2-4, gemtuzumab ozogamicin 3 mg/m(2) day 9) for relapsed or refractory elderly acute myeloid leukemia patients. We conducted this therapy for two refractory patients aged 56 and 63 and one relapsed 58-year-old patient. All three patients were induced complete remission after FLAG-MG therapy without serious complications.

AB - The institutional review board of our hospital approved FLAG-MG therapy (G-CSF 300 microg day 1-6, fludarabin 30 mg/m(2) day 2-6, Ara-C 1 g/m(2) day 2-6, mitoxantrone 5 mg/m(2) day 2-4, gemtuzumab ozogamicin 3 mg/m(2) day 9) for relapsed or refractory elderly acute myeloid leukemia patients. We conducted this therapy for two refractory patients aged 56 and 63 and one relapsed 58-year-old patient. All three patients were induced complete remission after FLAG-MG therapy without serious complications.

UR - http://www.scopus.com/inward/record.url?scp=74249099771&partnerID=8YFLogxK

M3 - 学術論文

C2 - 19915382

AN - SCOPUS:74249099771

SN - 0485-1439

VL - 50

SP - 663

EP - 665

JO - [Rinshō ketsueki] The Japanese journal of clinical hematology

JF - [Rinshō ketsueki] The Japanese journal of clinical hematology

IS - 8

ER -